PRGO Stock Analysis: Buy, Sell, or Hold?

PRGO - PERRIGO COMPANY PLC

PHARMACEUTICAL PREPARATIONS
$14.21
0.47 (3.42%) β–²
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026 24d

Get Alerted When PRGO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: PRGO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$13.30
Based on -0.3% avg growth
INTRINSIC VALUE TODAY
$8.26
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PRGO is currently trading at $14.21, which is considered fair relative to its 30-day fair value range of $13.85 to $14.95. The stock's valuation (Forward PE: 5.4) is in line with its historical norms (5.1). At these levels, the market is pricing in 2.0% annual earnings growth.

Technical Outlook: Technically, PRGO is in a strong downtrend. Immediate support is located at $13.58, while resistance sits at $15.38. The stock is showing strong short-term momentum, up 3.4% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.00 (+47.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $13.85 - $14.95
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 80.5%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.4%)
  • BULLISH: Trading 47.8% below Wall St target ($21.00)
  • BULLISH: Expecting earnings turnaround to 2.0% growth with -4.1% revenue growth

Fair Price Analysis

30-Day Fair Range $13.85 - $14.95
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $13.58
Resistance Level $15.38
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 5.37
Wall Street Target $21.00 (+47.8%)
Revenue Growth (YoY) -4.1%
Earnings Growth (YoY) -63.6%
Profit Margin -1.2%
Valuation Premium vs History +2.0% premium
PE vs Historical 5.4 vs 5.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.0% (market-implied from PE analysis)
1-Year Target $14.49 (+2%)
2-Year Target $14.78 (+4%)
3-Year Target $15.08 (+6%)
3-Yr Target (if PE normalizes) (PE: 5β†’5) PE COMPRESSION $14.32 (+1%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -4.5%) $51.39 (+262%)
Base: (SPY PE: 5.4, Growth: -4.5%) $12.37 (-13%)
Bear: (PE: 4.6, Growth: -4.5%) $10.52 (-26%)
Last updated: February 01, 2026 1:07 PM ET
Data refreshes hourly during market hours. Next update: 2:07 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Abigail Lennox BUY 1255 shares 2025-09-08
Robert Willis BUY 1488 shares 2025-08-22
Eduardo Guarita Bezerra BUY 3000 shares 2025-08-18

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$180 62 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$154 56 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$83 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$22 55 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 57 HOLD

Advanced PRGO Option Strategies

Professional options setups generated by AI based on today's PRGO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PRGO

PRGO Technical Chart PRGO Price Prediction PRGO Earnings Date PRGO Investment Advisor PRGO Fair Price Analyzer PRGO Options Advisor PRGO Options Chain PRGO Options Analysis PRGO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals